- Home
- BNR vs SDST Comparison
BNR vs SDST Comparison
Compare BNR & SDST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNR
- SDST
- Stock Information
- Founded
- BNR 2014
- SDST 2022
- Country
- BNR China
- SDST United States
- Employees
- BNR N/A
- SDST N/A
- Industry
- BNR Medical Specialities
- SDST Blank Checks
- Sector
- BNR Health Care
- SDST Finance
- Exchange
- BNR Nasdaq
- SDST Nasdaq
- Market Cap
- BNR 30.9M
- SDST 36.4M
- IPO Year
- BNR 2020
- SDST N/A
- Fundamental
- Price
- BNR $2.84
- SDST $0.50
- Analyst Decision
- BNR
- SDST Strong Buy
- Analyst Count
- BNR 0
- SDST 2
- Target Price
- BNR N/A
- SDST $1.73
- AVG Volume (30 Days)
- BNR 17.2K
- SDST 243.7K
- Earning Date
- BNR 05-28-2025
- SDST 05-15-2025
- Dividend Yield
- BNR N/A
- SDST N/A
- EPS Growth
- BNR N/A
- SDST N/A
- EPS
- BNR N/A
- SDST N/A
- Revenue
- BNR $70,669,261.00
- SDST N/A
- Revenue This Year
- BNR $136.32
- SDST $4,114.37
- Revenue Next Year
- BNR N/A
- SDST N/A
- P/E Ratio
- BNR N/A
- SDST N/A
- Revenue Growth
- BNR N/A
- SDST N/A
- 52 Week Low
- BNR $2.62
- SDST $0.41
- 52 Week High
- BNR $8.99
- SDST $28.38
- Technical
- Relative Strength Index (RSI)
- BNR 23.18
- SDST N/A
- Support Level
- BNR $2.77
- SDST N/A
- Resistance Level
- BNR $3.48
- SDST N/A
- Average True Range (ATR)
- BNR 0.35
- SDST 0.00
- MACD
- BNR 0.04
- SDST 0.00
- Stochastic Oscillator
- BNR 5.93
- SDST 0.00
About BNR Burning Rock Biotech Limited
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through our in-hospital model and smaller hospitals through our central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.
About SDST Stardust Power Inc. Common Stock
Stardust Power Inc is developing a lithium refinery at its Facility in Muskogee, Oklahoma, with planned capacity of producing up to 50,000 metric tons per annum of BGLC once fully operational. The company will source lithium brine feedstock from various suppliers and may make investments upstream to secure additional feedstock. The Company seeks to sell its products to electric vehicle (EV) manufacturers as the primary market, with potential applications in other areas such as battery manufacturers, the U.S. military, and original equipment manufacturers (OEMs).